deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT01165333

Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma (CILENT-0902)

Cilengitide (EMD121974) in Combination With Irradiation in Children and Young Adults With Newly Diagnosed Diffuse Intrinsic Pontine Glioma: Phase I Study

Sponsor: Centre Oscar Lambret

Conditions Diffuse Intrinsic Pontine Glioma
Interventions Cilengitide Cilengitide dose escalation Concomitant radiotherapy Exploratory investigation Pharmacogenetic Pharmacokinetic
Updated 5 times since 2017 Last updated: Feb 15, 2016 Started: Aug 31, 2010 Primary completion: Jan 31, 2014 Completion: Mar 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Diffuse Intrinsic Pontine Glioma, this trial is completed. The trial is conducted by Centre Oscar Lambret and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 20 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Oscar Lambret
Data source: Centre Oscar Lambret

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations